|Bid||3.53 x 1000|
|Ask||13.97 x 800|
|Day's Range||8.38 - 9.02|
|52 Week Range||7.23 - 16.53|
|Beta (5Y Monthly)||1.57|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 09, 2022 - Aug 15, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||19.25|
Subscribe to Yahoo Finance Plus to view Fair Value for TELA
Investors can approximate the average market return by buying an index fund. When you buy individual stocks, you can...
TELA Bio, Inc. (TELA) delivered earnings and revenue surprises of -50% and 4.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
MALVERN, Pa., May 10, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy, today reported financial results for the first quarter ended March 31, 2022. Recent Highlights Reported revenue of $8.2 million for the first quarter, representing growth of 40% over the corresponding p